Izanne Roos

39PUBLICATIONS
188CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 14, 2026
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 03, 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|Jul 03, 2026
Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Pageof 7

Frequent Collaborators

38 joint publications

Tomas Kalincik

20 joint publications

Anneke Van der Walt

11 joint publications

Francesco Patti

10 joint publications

Sara Eichau Madueño